This summer, the Krasnow Institute hosts a second Mason-Inova seminar series "Translational Research in Action."

Dr. Alessandra Luchini speaks June 14th, 2012, at 11 am on "Development and
Implementation of a Novel Nanotechnology for Cancer and Infectious Disease Diagnostics."
Dr. Luchini advises to Ceres Nanosciences (Ceres Nano), a startup based on Mason
technology developed in collaboration with Drs. Liotta, Petricoin and Bishop.
She is a co-author on multiple patents and scientific publications.
CeresNano uses unique properties of nanoparticles to accumulate and extract biomarkers
for diagnosis and treatment of Lyme disease, tuberculosis and cancer.
http://www.ceresnano.com/

Location: Krasnow lecture room, Fairfax Campus
Coffee and cookies are served.

The details/schedule will be posted on:
http://krasnow.gmu.edu/
http://mason.gmu.edu/~jberzhan/TranslationalResearchinAction/seminar1.html

-----
The Translational Research in Action Seminar objectives are:
1. to elucidate the path of scientific discovery to implementation in a clinical setting
2. to facilitate exchange of ideas for translational research collaborations at GMU
Invited speakers will come from the fields of basic research, clinical research or biomedical product development. The format will include a scientific core, an implementation case study (or proposed biomedical/behavioral relevance) and discussion.

For program questions and suggestions,
contact either Dr. Robert Lipsky, [log in to unmask]
or Dr. Julia Berzhanskaya [log in to unmask]
To be included on the mailing list (and for other organizational questions) email [log in to unmask]